Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 03:03PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.09 Insider Own27.54% Shs Outstand- Perf Week2.88%
Market Cap73.61M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float203.29M Perf Month-2.83%
Income-23.91M PEG- EPS next Q-0.04 Inst Own13.04% Short Float / Ratio0.95% / 1.96 Perf Quarter-31.84%
Sales8.84M P/S8.33 EPS this Y- Inst Trans-2.22% Short Interest1.93M Perf Half Y-50.96%
Book/sh0.35 P/B0.75 EPS next Y- ROA-27.07% Target Price1.30 Perf Year-24.66%
Cash/sh0.06 P/C4.09 EPS next 5Y- ROE-29.53% 52W Range0.20 - 0.73 Perf YTD6.17%
Dividend- P/FCF- EPS past 5Y14.18% ROI-23.50% 52W High-64.05% Beta1.53
Dividend %- Quick Ratio2.55 Sales past 5Y- Gross Margin27.13% 52W Low27.98% ATR0.02
Employees- Current Ratio2.67 Sales Q/Q27.26% Oper. Margin-346.50% RSI (14)50.37 Volatility6.46% 7.14%
OptionableNo Debt/Eq0.03 EPS Q/Q-29.02% Profit Margin-270.46% Rel Volume0.15 Prev Close0.26
ShortableYes LT Debt/Eq0.03 EarningsNov 14 AMC Payout- Avg Volume986.92K Price0.26
Recom1.00 SMA203.22% SMA50-1.66% SMA200-43.94% Volume125,364 Change1.73%
Today 08:00AM
Nov-28-23 08:00AM
Nov-27-23 08:00AM
Nov-16-23 08:00AM
Nov-14-23 04:25PM
08:00AM Loading…
Nov-08-23 08:00AM
Oct-16-23 08:00AM
Oct-10-23 08:00AM
Oct-05-23 04:05PM
Sep-12-23 08:00AM
Sep-11-23 08:00AM
Aug-30-23 08:17AM
Aug-28-23 08:00AM
Aug-11-23 09:15AM
08:05AM Loading…
Aug-09-23 08:05AM
Jun-27-23 08:00AM
Jun-21-23 08:00AM
Jun-16-23 08:00AM
Jun-08-23 08:00AM
May-28-23 06:36PM
May-24-23 08:10AM
May-16-23 05:02AM
May-15-23 08:22PM
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1998 and is headquartered in Seattle, WA.